A single center, single arm, prospective clinical study initiated by a researcher on the efficacy and safety of FCN-159 in the treatment of pediatric patients with type 1 neurofibromatosis associated with symptomatic and inoperable plexiform neurofibromatosis: Mid-term study report. - KIVIRID

A single center, single arm, prospective clinical study initiated by a researcher on the efficacy and safety of FCN-159 in the treatment of pediatric patients with type 1 neurofibromatosis associated with symptomatic and inoperable plexiform neurofibromatosis: Mid-term study report.

Authors: Yifan Liu, Qiaoyin Liu, ShengCai Wang, Xin Ni

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e22013

Source: Full article

Abstract

e22013